Manning & Napier Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$96M	Sell	229,630 -7,681	-3%	-$3.25M	1.1%	34
2023 Q4	$96.6M	Sell	237,311 -11,817	-5%	-$4.37M	1.15%	28
2023 Q3	$86.6M	Sell	249,128 -7,499	-3%	-$2.62M	1.07%	27
2023 Q2	$90.3M	Sell	256,627 -7,625	-3%	-$2.57M	1.03%	32
2023 Q1	$83.3M	Sell	264,252 -7,652	-3%	-$2.3M	0.97%	31
2022 Q4	$78.5M	Sell	271,904 -4,987	-2%	-$1.52M	0.97%	31
2022 Q3	$80.2M	Sell	276,891 -3,116	-1%	-$897K	1.05%	22
2022 Q2	$78.9M	Sell	280,007 -414,752	-60%	-$111M	0.91%	34
2022 Q1	$181M	Sell	694,759 -179,213	-21%	-$42.5M	1.73%	10
2021 Q4	$192M	Buy	873,972 +1,044	+0.1%	+$203K	1.6%	11
2021 Q3	$158M	Sell	872,928 -24,153	-3%	-$4.72M	1.36%	18
2021 Q2	$181M	Buy	897,081 +38,865	+5%	+$8.13M	1.48%	14
2021 Q1	$184M	Buy	858,216 +465,772	+119%	+$102M	1.57%	13
2020 Q4	$92.7M	Buy	392,444 +335,562	+590%	+$77M	0.86%	37
2020 Q3	$15.5M	Buy	56,882 +2,827	+5%	+$780K	0.16%	119
2020 Q2	$15.7M	Buy	54,055 +750	+1%	+$203K	0.17%	119
2020 Q1	$12.7M	Sell	53,305 -165,932	-76%	-$38.1M	0.15%	116
2019 Q4	$48M	Sell	219,237 -18,480	-8%	-$3.74M	0.52%	57
2019 Q3	$40.3M	Sell	237,717 -145,547	-38%	-$25.7M	0.45%	59
2019 Q2	$70.3M	Buy	383,264 +82,670	+28%	+$14.5M	0.76%	37
2019 Q1	$55.3M	Sell	300,594 -32,214	-10%	-$5.95M	0.61%	44
2018 Q4	$55.1M	Sell	332,808 -18,322	-5%	-$3.17M	0.67%	44
2018 Q3	$67.7M	Sell	351,130 -10,575	-3%	-$1.88M	0.67%	46
2018 Q2	$61.5M	Buy	361,705 +4,100	+1%	+$636K	0.61%	49
2018 Q1	$58.3M	Sell	357,605 -544,897	-60%	-$89M	0.57%	51
2017 Q4	$135M	Buy	+902,502	New	+$134M	1.22%	27